1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
Treatment of menorrhagia with intrauterine release of progesterone
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1983.tb08620.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 90, Issue 3, pages 255–258, March 1983
Additional Information
How to Cite
BERGQVIST, A. and RYBO, G. (1983), Treatment of menorrhagia with intrauterine release of progesterone. BJOG: An International Journal of Obstetrics & Gynaecology, 90: 255–258. doi: 10.1111/j.1471-0528.1983.tb08620.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Received 29 March 1982 Accepted 6 September 1982
- Abstract
- References
- Cited By
Summary. In 12 women with menorrhagia 80 ml per menstrual period) a progesterone-releasing device (Progestasert) was inserted. The women were followed by repeated measurements of the blood loss for 12 periods. The menstrual blood loss was significantly reduced after 1 month but the duration of bleeding was somewhat prolonged. Twelve months after insertion the menstrual blood loss amounted to 35% of the blood loss before the insertion. The Progestasert is a valuable treatment for menorrhagia.